Jason R. Williams, Founder and Director of Interventional Oncology and Immunotherapy at Williams Cancer Institute, shared All day Astronomy’s post on X, adding:
“Chemotherapy kills cancer cells. It also kills the immune cells that kill cancer cells. Most of oncology has accepted that trade-off. Dr. Pat Soon-Shiong never did. He built Anktiva, an IL-15 agonist that activates and expands your NK cells and T cells without triggering the suppressive cells that protect tumors. Saudi Arabia just approved it for lung cancer.
First country in the world to do so.
I’ve been using IL-15 intratumorally in combination with other immunotherapy agents for years. What Dr. Soon-Shiong is doing at the systemic level, we’re doing at the tumor level. The future of cancer treatment isn’t about finding better poisons. It’s about unlocking what’s already inside you.”
Quoting All day Astronomy‘s post:
“Japanese scientist Patrick Soon-Shiong has designed a treatment that activates body’s natural killer cells that fight against cancer cells.
Its approved in the U.S. and now Saudi Arabia has also approved it for its public.”
Other articles featuring Jason R. Williams and Patrick Soon-Shiong on OncoDaily.
